BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19190813)

  • 1. Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions.
    Daidone V; Cattini MG; Pontara E; Sartorello F; Gallinaro L; Marotti A; Scaroni C; Pagnan A; Casonato A
    Thromb Haemost; 2009 Feb; 101(2):298-304. PubMed ID: 19190813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome.
    Daidone V; Pontara E; Romualdi C; Cattini MG; Scaroni C; Albiger N; Pagnan A; Casonato A
    Thromb Res; 2010 Jun; 125(6):e275-80. PubMed ID: 20156642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the hypercoagulability of Cushing's syndrome.
    Daidone V; Boscaro M; Pontara E; Cattini MG; Occhi G; Scaroni C; Mantero F; Casonato A
    Neuroendocrinology; 2011; 93(2):121-5. PubMed ID: 21304226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.
    Casonato A; Daidone V; Sartorello F; Albiger N; Romualdi C; Mantero F; Pagnan A; Scaroni C
    Br J Haematol; 2008 Jan; 140(2):230-5. PubMed ID: 18173757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism.
    Chopra A; Kumar R; Kishore K; Tandon N; Yusuf T; Kumar S; Mishra P; Saxena R
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):514-9. PubMed ID: 22688555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forensic STRs as potential disease markers: a study of VWA and von Willebrand's Disease.
    Laird R; Schneider PM; Gaudieri S
    Forensic Sci Int Genet; 2007 Dec; 1(3-4):253-61. PubMed ID: 19083770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha.
    Szántó T; Schlammadinger A; Staelens S; De Meyer SF; Freson K; Pareyn I; Vauterin S; Hársfalvi J; Deckmyn H; Vanhoorelbeke K
    Thromb Haemost; 2007 Jul; 98(1):178-85. PubMed ID: 17598011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the VWF promoter (GT)n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditions.
    Hickson N; Hampshire D; Castaman G; Eikenboom J; Rodeghiero F; Peake I; Goodeve A;
    J Thromb Haemost; 2011 Mar; 9(3):603-5. PubMed ID: 21143374
    [No Abstract]   [Full Text] [Related]  

  • 10. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of type 1 von Willebrand disease.
    Goodeve A
    Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
    Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
    J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter.
    Keightley AM; Lam YM; Brady JN; Cameron CL; Lillicrap D
    Blood; 1999 Jun; 93(12):4277-83. PubMed ID: 10361125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-D-aspartate receptor subunit gene (GRIN2A) and schizophrenia.
    Tang J; Chen X; Xu X; Wu R; Zhao J; Hu Z; Xia K
    Neurosci Lett; 2006 Nov; 409(1):80-2. PubMed ID: 17011703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
    Jenkins PV; O'Donnell JS
    Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor short sequence repeat locus 2 (intron 40) consists of three polymorphic subloci.
    Othman M; Elbatarny HS; Byrne CD; O'Shaughnessy DF
    Acta Haematol; 2007; 117(3):177-80. PubMed ID: 17159339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.